| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/05/2007 | EP1861382A1 Fused aromatic compounds having anti-diabetic activity |
| 12/05/2007 | EP1861381A1 Novel 3-aryl-1,2-benzisoxazole derivatives, compostions containing same and use thereof |
| 12/05/2007 | EP1861380A1 2-(4-oxo-4h-quinazolin-3-yl)acetamides and their use as vasopressin v3 antagonists |
| 12/05/2007 | EP1861379A1 Tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents |
| 12/05/2007 | EP1861378A1 N-aryl-sulfoximine-substituted pyrimidines as cdk- and/or vegf inhibitors, their production and use as pharmaceutical agents |
| 12/05/2007 | EP1861377A1 Benzimidazolone derivatives as cb2 receptor ligands |
| 12/05/2007 | EP1861376A1 Cis-2,4,5-triaryl-imidazolines and their use as anti-cancer medicaments |
| 12/05/2007 | EP1861375A1 Dipyrazoles as central nervous system agents |
| 12/05/2007 | EP1861372A1 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| 12/05/2007 | EP1861371A1 Novel compounds ii 2-pyridine derivatives as inhibitors of neutrophile elastase. |
| 12/05/2007 | EP1861370A1 2-pyridine derivatives as inhibitors of neutrophile elastase |
| 12/05/2007 | EP1861368A1 Process for the preparation of 2-azabicycloý3.3.0¨octane-3-carboxylic acid derivatives |
| 12/05/2007 | EP1861366A2 Mitotic kinesin inhibitors |
| 12/05/2007 | EP1861365A1 N-sulphonylpyrroles and their use as histone deacetylase inhibitors |
| 12/05/2007 | EP1861363A1 Method of preparation of pure 4-pyrrolidinophenylbenzyl ether derivatives as maob inhibitors |
| 12/05/2007 | EP1861361A1 Glycopyrronium salts and their therapeutic use |
| 12/05/2007 | EP1861360A1 Pyrrolidine derivatives as histamine h3 receptor antagonists |
| 12/05/2007 | EP1861359A1 N-(n-sulfonylaminomethyl)cyclopropanecarboxamide derivatives useful for the treatment of pain |
| 12/05/2007 | EP1861358A1 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist, and pharmaceutical compositions containing the same |
| 12/05/2007 | EP1861357A1 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same |
| 12/05/2007 | EP1861356A1 Imines as ion channel modulators |
| 12/05/2007 | EP1861169A2 Method and composition for treating mucosal disorders |
| 12/05/2007 | EP1861130A2 Device and method for treatment of dermatomycosis, and in particular onychomycosis |
| 12/05/2007 | EP1861126A2 Treatment of protein degradation disorders |
| 12/05/2007 | EP1861113A2 Use of an onion extract for making a composition to control weight gain |
| 12/05/2007 | EP1861112A2 Compositions and methods for topical application and transdermal delivery of botulinum toxins |
| 12/05/2007 | EP1861111A2 Methods and compositions for increasing the safety and efficacy of albumin-binding drugs |
| 12/05/2007 | EP1861110A1 Antibiotic combinations for providing total solution to the treatment of infections |
| 12/05/2007 | EP1861109A2 Carotenoids, carotenoid analogs, or carotenoid derivatives for the treatment of proliferative disorders |
| 12/05/2007 | EP1861108A1 Antimicrobial compounds |
| 12/05/2007 | EP1861107A2 Treatment of amyotrophic lateral sclerosis with norethindrone and analogues |
| 12/05/2007 | EP1861106A2 Combination therapy for topical application in the treatment of age-related macular degeneration and ocular hypertension |
| 12/05/2007 | EP1861105A1 Process for the preparation of galanthamine hydrobromide |
| 12/05/2007 | EP1861104A2 Improved gacyclidine formulations |
| 12/05/2007 | EP1861103A1 Composition comprising ocaperidone |
| 12/05/2007 | EP1861102A1 Use of 2-anilino-3,4-dihydro-quinazolines as 5ht5a receptor antagonists |
| 12/05/2007 | EP1861101A2 Use of amides of sulfadimidine for the treatment of intestinal diseases in veterinary science |
| 12/05/2007 | EP1861100A1 3 , llB-CIS-DIHYDROTETRABENAZINE FOR THE TREATMENT OF A PROLIFERATIVE DISEASE OR AN INFLAMMATION |
| 12/05/2007 | EP1861099A2 Combination of a steroid sulfatase inhibitor and an ascomycin |
| 12/05/2007 | EP1861098A1 Anti-inflammatory compounds |
| 12/05/2007 | EP1861097A1 Mitotic kinesin inhibitors |
| 12/05/2007 | EP1861096A2 Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
| 12/05/2007 | EP1861095A1 Derivatives of imidazo(1,2-a)pyridine useful as medicaments for treating gastrointestinal diseases |
| 12/05/2007 | EP1861094A2 Histone deacetylase inhibitors sensitize cancer cells to epidermal growth factor inhibitors |
| 12/05/2007 | EP1861093A2 Organic nitric oxide enhancing salts of angiotensin ii antagonists, compositions and methods of use |
| 12/05/2007 | EP1861092A1 Potassium channel opener having benzofuroindole skeleton |
| 12/05/2007 | EP1861091A1 Compounds having lipid lowering properties |
| 12/05/2007 | EP1861090A1 Anti-inflammatory modalities |
| 12/05/2007 | EP1861089A1 Oral modified release formulations containing 8-prenylnaringenin for continuous estrogen support |
| 12/05/2007 | EP1861088A1 Medicament and treatment for herpes simplex |
| 12/05/2007 | EP1861087A2 Treatment with statin and omega-3 fatty acids and a combination product thereof |
| 12/05/2007 | EP1861086A2 Anti-proliferative combination therapy comprising satraplatin or jm118 and a taxane |
| 12/05/2007 | EP1861085A1 Antiviral compositions and methods of use |
| 12/05/2007 | EP1861084A1 Improved formulations of fenofibrate containing menthol or peg/poloxamer |
| 12/05/2007 | EP1861083A1 Composition based on an avermectin and azelaic acid in particular for treating rosacea |
| 12/05/2007 | EP1861082A1 A topical composition and its uses |
| 12/05/2007 | EP1861081A1 Ophthalmic uses of s1p receptor modulators |
| 12/05/2007 | EP1861080A1 Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1 ,4- benzoquinone for the treatment of muscular dystrophies |
| 12/05/2007 | EP1861079A1 Arylsulfonyl benzyl ethers as 5-ht2a antagonists |
| 12/05/2007 | EP1861078A2 A capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom |
| 12/05/2007 | EP1861077A1 Non invasive method for prevention and treatment of cancer |
| 12/05/2007 | EP1861074A1 Taste masked dosage form containing roflumilast |
| 12/05/2007 | EP1861073A2 Process for the production of calcium compositions in a continuous fluid bed |
| 12/05/2007 | EP1860944A2 Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections |
| 12/05/2007 | EP1860943A2 Novel method |
| 12/05/2007 | EP1860942A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof |
| 12/05/2007 | EP1784498A4 Systems and methods for inhibiting metastasis |
| 12/05/2007 | EP1773841B1 Mixed solvate of olanzapine, method for preparing it and method for preparing form i of olanzapine therefrom |
| 12/05/2007 | EP1768973B1 Substituted quinolones |
| 12/05/2007 | EP1720848B1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors |
| 12/05/2007 | EP1711508A4 6r-(3,6-dideoxy-l-arabino-hexopyranosyloxy)heptanoic acid, preparation process for the same and dauer effect thereof |
| 12/05/2007 | EP1670415A4 Animal model for protease activity and liver damage |
| 12/05/2007 | EP1663197B1 The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma |
| 12/05/2007 | EP1658288B1 2-amino-5-benzoylthiazole npy antagonists |
| 12/05/2007 | EP1656183B1 Treatment of male sexual dysfunction |
| 12/05/2007 | EP1638544B1 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions |
| 12/05/2007 | EP1608335B1 Controlled release system containing saccharose acetate isobutyrate |
| 12/05/2007 | EP1594472B1 Delivery of a nsaid from embolic agents |
| 12/05/2007 | EP1585510B1 Alpha-aminoamide derivatives useful as antimigraine agents |
| 12/05/2007 | EP1554262B1 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 12/05/2007 | EP1539196B1 Vitreoretinal tamponades based on fluorosilicone fluids |
| 12/05/2007 | EP1501522A4 Preblocking with non-ha gags increases effectiveness of ha conjugated anticancer agents |
| 12/05/2007 | EP1499319B1 Bicyclo 4.4.0 antiviral derivatives |
| 12/05/2007 | EP1492876B1 Cationic amphiphiles for intracellular delivery of therapeutic molecules, composition, process and use thereof |
| 12/05/2007 | EP1485359B1 Sodium channel blockers |
| 12/05/2007 | EP1433479B1 Appetite-stimulating agents and remedies for anorexia |
| 12/05/2007 | EP1404324B1 Prodrugs of gaba analogs, compositions and uses thereof |
| 12/05/2007 | EP1399420B1 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 12/05/2007 | EP1368318B1 Calcilytic compounds |
| 12/05/2007 | EP1362844B1 Benzylamine analogue |
| 12/05/2007 | EP1339440B1 An implantable or insertable therapeutic agent delivery device |
| 12/05/2007 | EP1305329B1 6.alpha.,9.alpha.-difluoro-17.alpha.-(2-furanylcarboxyl)oxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 12/05/2007 | EP1292278B1 Preparations that contain an extract of the plant pistia stratiotes |
| 12/05/2007 | EP1289489B1 Topical agent for dermatological use containing 4-hydroxyphenyl-alpha-d-glucopyranoside |
| 12/05/2007 | EP1272458B1 Arginine mimetics as factor xa inhibitors |
| 12/05/2007 | EP1263752B1 Lpa receptor agonists and antagonists and methods of use |
| 12/05/2007 | EP1248599B1 Multi-particulate form of medicament, comprising at least two differently coated forms of pellet |
| 12/05/2007 | EP1208085B1 Benzanilides as potassium channel openers |
| 12/05/2007 | EP1170006B1 Drug for alleviating migrane |
| 12/05/2007 | EP1169294B1 Pharmaceutical compounds |